Cardiac abnormalities in primary hyperoxaluria.
暂无分享,去创建一个
[1] Jonas Crosby,et al. Regional myocardial long-axis strain and strain rate measured by different tissue Doppler and speckle tracking echocardiography methods: a comparison with tagged magnetic resonance imaging. , 2009, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[2] Olivier Gerard,et al. Assessment of subendocardial vs. subepicardial left ventricular rotation and twist using two-dimensional speckle tracking echocardiography: comparison with tagged cardiac magnetic resonance. , 2009, European heart journal.
[3] S. Cha,et al. Doppler strain imaging closely reflects myocardial energetic status in acute progressive ischemia and indicates energetic recovery after reperfusion. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[4] S. Abdelwhab,et al. Pulmonary Hypertension in Chronic Renal Failure Patients , 2008, American Journal of Nephrology.
[5] Bijoy K Khandheria,et al. Twist and untwist mechanics of the left ventricle. , 2008, Heart failure clinics.
[6] S. Miyazaki,et al. L-carnitine supplementation decreases the left ventricular mass in patients undergoing hemodialysis. , 2008, Circulation journal : official journal of the Japanese Circulation Society.
[7] H. Shimokawa,et al. Prognostic importance of chronic kidney disease in Japanese patients with chronic heart failure. , 2008, Circulation journal : official journal of the Japanese Circulation Society.
[8] Eloisa Arbustini,et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2007, European heart journal.
[9] G. Rumsby,et al. Selected exonic sequencing of the AGXT gene provides a genetic diagnosis in 50% of patients with primary hyperoxaluria type 1. , 2007, Clinical chemistry.
[10] J. De Sutter,et al. Heart failure with mitral valve regurgitation due to primary hyperoxaluria type 1: case report with review of the literature , 2007, Acta cardiologica.
[11] Barry J Maron,et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd , 2006, Circulation.
[12] William Stewart,et al. Recommendations for chamber quantification. , 2006, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[13] R. Wachter,et al. Restrictive cardiomyopathy in a patient with primary hyperoxaluria type II , 2006, Clinical Research in Cardiology.
[14] Richard B Devereux,et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[15] E. Bergstralh,et al. International Registry for Primary Hyperoxaluria , 2005, American Journal of Nephrology.
[16] D. Milliner. The Primary Hyperoxalurias: An Algorithm for Diagnosis , 2005, American Journal of Nephrology.
[17] M. Coulter-Mackie,et al. Evaluation of mutation screening as a first line test for the diagnosis of the primary hyperoxalurias. , 2004, Kidney international.
[18] L. Biblo,et al. Type I Primary Hyperoxaluria: An Unusual Presentation of Ventricular Tachycardia , 2003, Cardiology in review.
[19] B. Hoppe,et al. A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria , 2003, Pediatric Nephrology.
[20] D. Milliner,et al. Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II. , 2002, Kidney international.
[21] M. Meurisse,et al. Reversal of oxalosis cardiomyopathy after combined liver and kidney transplantation , 2002, Transplant international : official journal of the European Society for Organ Transplantation.
[22] M. Hori,et al. Echocardiographic Features in a Patient with Primary Oxalosis , 2001, Echocardiography.
[23] B. Hoppe,et al. The primary hyperoxalurias. , 2001, Journal of the American Society of Nephrology : JASN.
[24] C. Langman. The optimal approach to the patient with oxalosis. , 2001, Advances in renal replacement therapy.
[25] E. Duhig,et al. Primary oxalosis with cardiac involvement: echocardiographic features of an unusual form of cardiomyopathy. , 2001, Circulation.
[26] J. Feingold,et al. Estimating prevalence in single-gene kidney diseases progressing to renal failure. , 2000, Kidney international.
[27] S. Cramer,et al. The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with primary hyperoxaluria type II. , 1999, Human molecular genetics.
[28] B. Hoppe,et al. Plasma calcium-oxalate saturation in children with renal insufficiency and in children with primary hyperoxaluria. , 1998, Kidney international.
[29] J. Machac,et al. Reversal of primary hyperoxaluria cardiomyopathy after combined liver and renal transplantation. , 1995, The American journal of cardiology.
[30] P. Desmond,et al. Primary hyperoxaluria type I. , 1994, Australasian radiology.
[31] R. Watts. Primary hyperoxaluria type I. , 1994, QJM : monthly journal of the Association of Physicians.
[32] R. Rodby,et al. Reversal of cardiac dysfunction secondary to type 1 primary hyperoxaluria after combined liver-kidney transplantation. , 1991, The American journal of medicine.
[33] C. Danpure. Molecular and clinical heterogeneity in primary hyperoxaluria type 1. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[34] G. Devault,et al. Reversal by liver transplantation of the complications of primary hyperoxaluria as well as the metabolic defect. , 1989, The New England journal of medicine.
[35] B. Massie,et al. Primary oxalosis with pan-conduction cardiac disease: electrophysiologic and anatomic correlation. , 1981, Circulation.
[36] K. Hamaya,et al. PRIMARY OXALOSIS WITH CARDIAC MANIFESTATIONS , 1980, Acta pathologica japonica.
[37] A. Tonkin,et al. Primary oxalosis with myocardial involvement and heart block. , 1976, The Medical journal of Australia.
[38] Hutchins Gm,et al. Adult-onset primary oxalosis with complete heart block. , 1973 .
[39] R. Hudson,et al. Primary oxalosis of the heart: a cause of heart block. , 1971, British heart journal.
[40] Y. Ozaki,et al. Long term prognosis of chronic heart failure: reduced vs preserved left ventricular ejection fraction. , 2009, Circulation journal : official journal of the Japanese Circulation Society.
[41] D. Milliner,et al. Phenotypic expression of primary hyperoxaluria: comparative features of types I and II. , 2001, Kidney international.
[42] S. Cramer,et al. Erratum: The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with primary hyperoxaluria type II (Human Molecular Genetics (1999) 8 (2063-2069)) , 1999 .
[43] Ronald J. Prineas,et al. The Minnesota code manual of electrocardiographic findings : standards and procedures for measurement and classification , 1982 .
[44] G. Hutchins,et al. Adult-onset primary oxalosis with complete heart block. , 1973, The Johns Hopkins medical journal.